Profile
International Journal of Clinical Nutrition & Dietetics Volume 4 (2018), Article ID 4:IJCND-128, 11 pages
https://doi.org/10.15344/2456-8171/2018/128
Original Article
Dyslipidemia and Other Risk Factors Among Egyptian Patients with Type-2 Diabetes Mellitus and the Impact of Dietary Intervention with Thermally Treated Tomato Juice

Laila Hussein1*, Sancia Gaetani2, Sabila G Mousa3, Laura D'Evoli2 and Nahed Hussein4

1National Research Center, Department of Nutrition, Giza, Egypt
2National Research Institute on Food and Nutrition, Rome, Italy
3Faculty of Medicine, Dept Internal Medicine, El Azhar Univ., Cairo, Egypt
4Faculty of Special Education, Dept nutrition, Ain Shams Univ, Cairo, Egypt
Dr. Laila Hussein, National Research Center, Department of Nutrition, Giza, Egypt; E-mail: dr.lailahussein@yahoo.com
11 January 2018; 17 February 2018; 19 February 2018
Hussein L, Gaetani S, Mousa SG, D'Evoli L, Hussein N (2018) Dyslipidemia and Other Risk Factors Among Egyptian Patients with Type-2 Diabetes Mellitus and the Impact of Dietary Intervention with Thermally Treated Tomato Juice. Int J Clin Nutr Diet 4: 127. doi: https://doi.org/10.15344/2456-8171/2018/127

Abstract

The increase in the plasma level of lycopene following the drinking of tomato juice is a valid biomarker reflecting lowering in the oxidative stress and improving glycemic control among patients with type 2 Diabetes Mellitus (T2 DM).
The aim of the study is to characterize the overall health of a small sample of typical patients with type 2 DM and to test the effectiveness of dietary intervention with tomato juice against the oxidative stress of diabetes.
Design: The study consisted of 29 diabetic men and women with mean age of 61 years and median duration of diabetes of 12 years. Blood samples were collected for biochemical analysis of 14 blood biomarkers. The participants were then divided into two groups, one arm served as control and the second received daily 240 ml of thermally treated tomato juice providing 22 mg of lycopene. At days zero and at the end of the 3 week dietary intervention, blood samples were collected for HPLC measurement of plasma carotenoids and retinol concentrations.
Results: The fasting plasma glucose (FPG) concentrations of 46.7 % of the diabetic men and 40% of the diabetic women were ≤ 7.0 implying good management. The use of HbA1c as criteria of good control of glycemic index, 78.6 % of the diabetic men and 88.9% of the diabetic women were presented with poorly glycemic control. Prevalences of obesity (BMI > 30 kg/ m2) accounted for 44 % and 87.5% among the diabetic men and women, respectively. Prevalences of total cholesterol high density lipoprotein ratio above the acceptable upper limit were 33.3 and 25 % among diabetic men and women, respectively. Prevalences of hyper triglyceridemia were 69.2 and 60% among the diabetic men and women, respectively. After the 3 week dietary intervention with thermally treated tomato juice, plasma lycopene concentration increased on average by 161% fold excess over the respective baseline level, reflecting lowering in the oxidative stress and improving glycemic control of T2 DM pathogenesis. The preliminary data recommends the regular intakes of tomato lycopene rich diets as a safe adjunct to glucose-lowering drugs among diabetics with poor glycaemic control and with increased levels of oxidative stress biomarkers.


1. Introduction

Diabetes Mellitus (T2DM) has reached epidemic proportions worldwide due to the economic growth, over nutrition and obesity factors [1]. The Western dietary pattern was associated with an elevated risk, whereas the grains-vegetables dietary pattern was associated with a reduced risk of T2 DM among middle aged Chinese adults [2]. Older adults with diabetes are at risk of developing spectrum of macrovascular and microvascular complications as their younger counterparts with diabetes [3]. Other risk factors include obesity and a sedentary lifestyle, which play important roles in escalating the prevalence of diabetes [4]; in particular, obesity at a young age [5]. Advanced glycation end products (AGEs) derived from food increase reactive oxygen species formation and impair antioxidant systems, and they have been assumed as risk factors for T2DM [6,7]. AGE derived from protein–carbonyl reactions or advanced lipoxidation end products (ALEs) contribute especially in diabetic patients to a significant accumulation of AGEs/ALEs in the tissues [8]. In the United States, the consumption of high fructose corn syrup (HFCS) increased > 1000% between 1970 and 1990, far exceeding the changes in intake of any other food or food group [9]. HFCS is the major source of caloric sweeteners in soft drinks and many other sweetened beverages and its regular intake is implicated in numerous other foods [10]. Glycated hemoglobin [HbA1c], which is deeply involved in T2 DM is the most well studied example of AGE [11].

With systemic insulin resistance, insulin signaling within glucose recipient tissues is defective and beta cell dysfunction results from inadequate glucose sensing elevated blood glucose concentrations [12] , which accelerate aging [13]. Hyperglycemia is suggested to be the main cause of diabetic complications, decrease life quality and expectancy, and becomes a financial burden for health care systems [6]. The underlying mechanisms of T2 DM lies on the condition of oxidative stress, due to free radical over production and decreased antioxidant defences [14] and also to defects in the dentate gyrus of the hippocampus [15]. Positive association exists between glucose levels and diabetic microvascular complications particularly diabetic retinopathy [16].

The serum C-peptide (31-amino-acid residues) is produced in equal amount with that of insulin cleaved from proinsulin [17] with longer degradation rate in the body with the half-life of 20-30 min) compared with that of insulin (3-5 min) and measurement of C-peptide levels in insulin-treated diabetics avoids the problems of cross-reaction of assay between exogenous and endogenous insulin. Fasting plasma concentration of C-peptide among normals range between 0.3-0.6 nmol/l, with a postprandial increase to 1-3 nmol/l and its concentration is associated with duration and comorbidities of disease [18]. Retinol binding protein -4 (RBP4) has recently gained a lot of attention because it is a novel adipokine predominantly secreted by adipocytes from visceral adipose tissue and its level is elevated in diabetic patients compared with healthy subjects correlated positively with triglyceride, systolic blood pressure [19].

The longer diabetes has been present, the more likely patients are to require insulin to control their hyperglycemia and hyperglycemia in these patients is often not well controlled and effective clinical management is problematic. Food antioxidants with scavenging ability serve as a defense system against the oxidative stress may play a protective role in initiating intervention for primary and second prevention of T2 DM.

Tomatoes lycopene has unique biological properties by exhibiting a physical quenching rate constant with singlet oxygen and clinical evidence supports its important health benefits [20]. Drinking two glasses of tomato juice; providing daily roughly 40 mg of lycopene inhibited platelet aggregation in patients with T2 DM [21]. The increase in the plasma level of lycopene following the drinking of tomato juice is a valid biomarker implying good management and reflecting lowering in the oxidative stress among the study subjects.

Carotenoids demonstrate vital biological roles in the eye, both functionally as precursors to retinol in the visual pathway (provitamin A (PVA carotenoids) and structurally as macular pigments. Lycopene is present in high concentrations in the human retinal pigment epithelium choroid [22] and the combined plasma lycopene and lutein/zeaxanthin (non-pro-vitamin A (non-PVA) carotenoid) concentration was significantly lower in the T2 DM retinopathy than non-retinopathy group [23] compared with the pro-vitamin A (PVA) carotenoids (α-carotene, β-carotene and β-cryptoxanthin). Low molecular weight soluble fraction of tomato paste are also strong inhibitors against the formation of AGE [24].

The goal of the present study is to carry out laboratory investigations on Egyptian patients with long duration of type- 2 diabetes mellitus (T2DM) to obtain analytical data on 14 blood components and to examine their potential potency as dietary and health related biomarkers. The impact of dietary intervention with thermally treated tomato juice on the plasma level of lycopene is tested and elevated plasma levels were considered valid biomarker reflecting lowering in the oxidative stress among the study subjects.

2. Subjects

2.1 Eligibility and Enrollment

Twenty nine subjects (19 M, 10F) were recruited from the outpatient clinic of Kobry El Kobbah insurance hospital with complete data sets from all sessions. To be eligible, participants had to be ≥ 50 years, have diabetes mellitus (DM) and taking at least one anti-diabetic medication. Individuals were excluded if they had any major medical (eg, cancer, chronic liver disease, chronic kidney disease, hemodialysis, glucocorticoid treatment, pregnancy) or psychiatric disorders that would prevent full participation. The study received the approval from the Ethical Committee of Kobry El Kobbah insurance hospital, Cairo, which complied with the Declaration of Helsinki guidelines (2004). The protocol was fully explained to all subjects and written informed consent was obtained before their participation in the trial.

2.2 Data Collection

Demographic factors were assessed via a patient questionnaire. At baseline, a standard questionnaire concerning date of birth, sex, education, smoking habit, health-related information history and medications were obtained by face-to-face interviews. The investigator received extensive training specifically for this questionnaire. All subjects had a physical examination including measurement of height and weight. Body mass index (BMI) was calculated as weight (kg) divided by the square of height in meters (m2). Blood pressure was measured on the right arm three times consecutively at 1-min intervals, with the mean of the three measurements used for analysis.

2.3 Design of the dietary intervention randomized controlled trial

The participants were divided into two groups, whereby one arm served as control group and didn’t receive any supplement; while the second group was assigned to the tomato juice. Each participant took 7 tomato juice bottles back home once a week, and the process was repeated on three consecutive weeks. The participants were instructed not to alter their usual diet and not to change the dosage of insulin or the oral glucose lowering drugs and to adhere to the following protocol. To keep the bottles frozen at -200C except the bottle they drank the following day.

2.4 Thermally treated tomato juice with added corn oil

Ripe large size full color tomatoes were purchased as a single batch. After cleaning, washing and homogenizing in a Waring blender, the resulting juice was poured in a 100 liter capacity porcelain- lined reactor adapted with mechanical stirrer and thermostat (Pilot plant - NRC, Egypt). The tomato juice was heated to 750C with live steam and the temperature was stabilized for 20 minutes, then cooling started. When the temperature reached 450C, maize oil was added to the juice under mechanical stirring to 4 % final concentration (w/w). Upon cooling, the tomato juice was packed in 240 ml aliquots in polyethylene container with air tight cover and saved frozen in a deep freezer at -200C.

2.5 Laboratory investigations

2.5.1 Blood sampling

The participants were asked to come to the clinic in the morning after at least 8 h of overnight fasting and before taking any drug at day zero (baseline data) and day 22 (The last day of intervention). Standard clinical venipuncture methods were used for the blood sampling without anticoagulants to determine glucose concentrations. The blood samples were centrifuged and serum supernatant fractions were stored frozen at -30° C for the analysis of serum lipid profile and C-peptide. A blood aliquot was transferred to a heparinized tube and immediately centrifuged and the plasma was stored frozen at -30°C for the determination of plasma carotenoids and retinol.

2.5.2 Laboratory investigations

Fasting and 2h post prandial (after the 75 g oral glucose tolerance test) blood glucose were measured by the hexokinase method with a Boehringer Mannheim Hitachi kit. Glycosylated hemoglobin was measured on micro-column (Bio-Rad). Serum total cholesterol (Cat No CH 200), triglyceride (Cat No TR 1575) and HDL-cholesterol (HDL-C) was assayed after precipitation of the apo β-containing lipoproteins with phosphotungstic acid and magnesium ions with commercial kit (Biodiagnostics, Egypt). Measurements were done by the enzymatic colorimetric endpoint assays according to the instruction of the Kit’s manufacturer. The performance of these assays was regularly certified by reference plasma samples. The Friedewald equation [25] was used for calculating plasma LDL-cholesterol.

Plasma LDL-C (mmol/l ) = TC (mmol/l) – ((HDL-C mmol/ l + TG mmol/l /5)

The level of serum C-reactive protein was assessed by the latex method. Plasma C- peptide was assayed by immune assay method (Roche kit, Catalog Number: 03184897190) on Cobase 411 analyzer according to instruction of the manufacturer.

2.6 HPLC separation of plasma carotenoids

Plasma carotenoids were measured within few weeks from the date of blood collection and β-carotene has been shown to be stable at -350C up to 22 mo [26]. The two plasma samples for each subject (baseline and sample collected after 3 weeks intake of tomato juice) were analyzed on the same day. The plasma was thawed and aliquots of 460 μl were pippeted in a 2.2-ml Eppendorf centrifuge tubes. Additions of 100 μl of Apo-β-carotenal as internal standard, 460 μl absolute ethanol (containing 1 mg ascorbic acid/mL) and 900 μl of n-hexane (containing 0.1% butylated hydroxytoluene/ mL) were done in this sequence. After vigorous vortexing and centrifugation (Biofuge-Fresco, Heraues, Germany), the upper layer was aspirated, and the extraction was repeated twice. The pooled hexane supernatant was evaporated to dryness under nitrogen at 400C and the residue was resuspended in 100 μl of the mobile phase.

The chromatographic system consisted of HPLC instrument equipped with pump 600 and controller 600 (Waters Associates, Milford, MA). The analytical column consisted of a 4.6x 250 mm column (GI Sciences, Japan) packed with Inertsil ODS, 5 μm and 100 % isocratic mobile phase consisting of acetonitrile-dichloromethane -methanol (70:20:10 v/v) at a flow rate of 1ml/min. A Waters model multichannel photodiode detector was used to monitor absorbance at 450 nm. Lutein and zeaxanthin were not separable and are reported together as lutein, because lutein is usually present in larger concentrations than zeaxanthin. Calibration was performed with pure compounds of α-; β- carotenes; lycopene, β-cryptoxanthin and lutein [Sigma -Aldrich]. Standard β-carotene, the internal standard apo-β- carotenal (Fluka) were prepared by dissolving in the recommended solvent. The concentrations of the standards was determined by visible spectrophotometry. Because the standard α-carotene was not available, this compound was quantified by using the response factor for the all-trans β- carotene isomer. The lutein, β-apo-8-carotenal, β-cryptothanthin, lycopene, α-Carotene and β- carotene peaks appeared at retention times of 4.3 ; 6.26; 8.2, 10.49, 15.7; 16.8 minutes, respectively (Table 1). The column was rinsed for additional 5 min with the mobile phase before the injection of the next sample; 21 min were elapsed between two consecutive injections. The carotenoid concentration was determined by the external standard curve procedure. The peak areas of the unknown samples were integrated and the results were compared with the respective peak areas of the carotenoid standard having the same retention time. These peak areas were used to create the calibration graph and to calculate the regression coefficients.

table 1
Table 1: Physical characteristics of the carotenoids and retention time of the carotenoid peaks.

2.7 Separation of retinol by HPLC technique [29]

Eppendorf tubes containing aliquots of 150 μl plasma and 50 μl of the internal standard retinyl acetate were mixed with equal volume of acidic propanol to denature the proteins, followed by extraction with hexane (1 ml). Following vigorous vortexing and centrifugation, aliquots of the clear hexane layer (850 μl) were aspirated and saved in glass tubes in dim light. The extraction process was repeated and the supernatants were pooled. The hexane extract was evaporated under a stream of nitrogen and reconstituted in 200 μl methanol under vortexing for complete dissolution.

HPLC separation: The same HPLC system mentioned above was used for the separation of plasma retinol [29]. The gradient for the mobile phase was acetonitrile, water and aqueous acetic acid (2%) at a ratio of 85: 13: 2. Aliquots of the sample and standard extracts (20 μl) were manually injected with a flow rate of 1.5 ml / min and the monitoring wave length was 325 nm. Signals from the Waters 996 photodiode array detector was recorded simultaneously by the data system. Plasma retinol concentration was determined by the internal standard curve method, and calculations were done using Ezchrom chromatography data system version 2.1. The preparation of standard curve and the quality control were carried out as reported earlier [29].

Quantitative assay of retinol binding protein (RBP-4) by Western blotting technique Immuno detection was performed with a polyclonal full-length recombinant RBP4 antibody to human RBP4 (Dako Cytomation). Analysis of tomato juice for carotenoid pigments.

The carotenoid content of the tomato juice was determined after extensive extraction of the juice with tetrahydrofuran/methanol (1:1, v/v) until the last extract was colorless (usually five times extractions). An aliquot was taken and the compound ethyl-β-apo-carotenoate was added as an internal standard. HPLC separation was completed on a column packed with ET 200/4 nucleosil 100–5CN (Machery& Nagel, Duren, Germany).

2.8 Composition of the mobile phase for gradient elution

Time (Min) Heptane (v/v %) Isopropanol (v/v %)
0-3 97 2.5
3-15 50 50
16-30 97 2.5

At a flow rate of 1.0 mL/min and column temperature of 20°C. The eluent was monitored by visible detection at 450 nm for β-carotene and at 470 nm for lycopene. In this system, α-carotene co-elutes with β –carotene, but tomato doesn’t contain α -carotene [30], the HPLC response with retention time of 14–17 minutes was practically β -carotene.

2.9 Statistical analysis

The results are expressed as means ±SE. Whisker box plots were plotted to investigate the the variability in the blood glucose concentrations, body mass index and the serum lipid profiles and plasma lycopene according to sex. At the completion of the three week dietary intervention study each treated individual was compared with the respective pre feeding (baseline) level. The paired t- test was used to analyze normally distributed data. Nonparametric statistical tests were performed and significance was accepted if the null hypothesis was rejected at the P< 0.05 level. Statistical analysis was performed with the Microsoft exel statistical software.

3. Result

Table (2) presents the baseline characteristics of the diabetic men and women whose average age were 61 and 62 years, respectively. Duration of diabetes averaged 11.6 years (5-25 years). Based on the BMI data (BMI > 30 kg/m2), a 33.3% and 87.5% of the diabetic men and women were obese. 84% of the diabetic men received daily insulin injection versus 33.3% of the diabetic women; the rest i.e. 16 % of the diabetic men and 66.7% of the diabetic women were treated with oral therapy.

The fasting blood glucose (FPG) levels (≤7 mmol/l) [31] was acceptable among 46.7% and 40% of the diabetic men and women, respectively.

The standard acceptable glycemic index is equivalent to HbA1c level ≤ 6.5 % and only 7% of the diabetic men and 44 % of the diabetic women satisfied this criteria; the glycemic index of a higher proportion of the diabetic women was better controlled than that of the diabetic men (Chi square test = 4.48; P< 0.05).

When the glycemic index (HbA1c) for diabetics was set at 9%; 78.6 % and 88.9% of the diabetic men and women, respectively fell within this figure.

FPG is the gold standard and it correlates positively and significantly with HbA1c r = 0.5321 (P<0.01) and r = 0.9534 (P<0.001) for diabetic men and women, respectively. The respective regression equations are ȳ Predicted fasting glucose concentration among diabetic men = 1.26 x + 0.1025; ȳ Predicted fasting glucose concentration among diabetic women = 2.12 x - 6.26.

The plasma lipid profiles are characterized by hypertriglyceridemia i.e above upper normal limit of plasma triglyceride (1.7 mmoles/l) among 69.2 and 60 % of the diabetic men and women, respectively. Acceptable serum HDL-C of 58% and 60% were found among diabetic men (>1.09mmol/l) and women (1.3mmol/l), respectively. Serum triglycerides correlated negatively with serum HDL-C only among the diabetic men with correlation coefficient of -0.4607 (P<0.01). Whisker box plot illustrates the concentrations of serum triglyceride, total cholesterol and high density lipoprotein cholesterol among the diabetic men and women.

figure 1
Figure 1: (A) Fasting and post prandial plasma glucose levels (B) Glycated hemoglobin (HbA1c) concentrations among diabetic men and women. Boxes represent the interquartile range (IQR) and the line inside represents the median. Whiskers denote the lowest and highest values.
figure 2
Figure 2: Body mass index (BMI) among diabetic men and women Boxes represent the interquartile range (IQR) and the line inside represents the median. Whiskers denote the lowest and highest values.

Metabolic syndrome (MS) The criterion used for defining MS are the followings: Waist circumference (cm) <94 (male); <80 (females); Glucose (mmol/L) <5.6; HDL cholesterol (mmol/L) ≥1.03 (male); >1.29 (females); Triglycerides (mmol/L) ≤1.7; Systolic pressure (mm Hg) <130; Diastolic pressure (mm Hg) <85 [32]. Based on the above mentioned criterion, MS was found among 22.2% of diabetic women and 8.0% among the men and Chi square test revealed statistical significant differences (P<0.05).

Serum C- peptide levels averaged 1.3 nmoles/l, with no differences between sexes. Acceptable levels were found among all participants, except for two hyperglycemic diabetic women whose serum C-peptide levels were <0.2 nmol/l. Such low serum C-peptide level reflects absolute insulin deficiency/absolute insulin requirement [33,34] Serum C -peptide correlated negatively and significantly with FPG r =-0.3086 (P< 0.05) and women r = -0.6959 (P<0.1) among diabetic men and women, respectively.

3.1 Plasma carotenoids and retinol

A representative HPLC chromatogram demonstrates the separation of the 5 major carotenoids and the internal standard from the authentic carotenoids and a plasma extract of a participant. The retention times of lutein; internal standard β-apo-8-carotenal; β- cryptoxanthin; lycopene; α carotene and β- carotene were 4.3; 6.26; 8.2; 10.49; 15.7 and 16.8 minutes respectively.

Table 2 presents baseline level of plasma carotenoid concentrations among the diabetic men and women. The mean concentrations of α, β- carotene, cryptoxanthin and lycopene were higher among the diabetic women than the respective mean values of the men; however, only mean serum β-carotene concentration attained significant differences (P<0.05).

table 2
Table 2: Baseline characteristics of the diabetic men and women.

3.2 The composition of the thermally treated tomato juice

The analysis of the thermally treated tomato juice is presented in Table 3. The daily portion of 240 ml provided 22.3 mg lycopene, 1.32 mg ß-carotene and 26 mg total polyphenolic compounds.

table 3
Table 3: Mean contents of carotenoid pigments and polyphenolic compounds in thermally treated tomato juice consumed by the participants.

Table 4 presents the mean plasma α, β-carotene, cryptoxanzin, lutein and lycopene among the diabetics at the start and end of the 3 week dietary intervention.

table 4
Table 4: Mean plasma carotenoids concentrations before and following the three week dietary intervention with thermally treated tomato juice.

At the end of the 3 week intake of tomato juice, the mean change in the plasma lycopene concentration increased by 161 % compared to the respective prefeeding level (Figure 4).

figure 3
Figure 3: Serum triglyceride (TG), total cholesterol (TC) and high density lipoprotein cholesterol (HDL-C) concentrations among diabetic men and women. Boxes represent the interquartile range (IQR) and the line inside represents the median. Whiskers denote the lowest and highest values.
figure 4
Figure 4: HPLC chromatogram for the separation and retention times of 5 carotenoid pigments from the authentic material (Bottom) and in the plasma extract of one participant.

The consumption of tomato juice was also associated with % increase in the mean concentrations of α-, β-carotenes and lutein. Mean plasma β- cryptoxanthin concentration decreased following the consumption of tomato juice. The ratio of combined plasma lycopene and lutein/zeaxanthin (non-pro-vitamin A (non-PVA) carotenoid) concentration to the pro-vitamin A (PVA) carotenoids (α-carotene, β-carotene and β-cryptoxanthin increased slightly following the 3 week dietary intervention with tomato juice, relative to the respective prefeeding mean level, but the difference didn’t reach significant value (P>0.05).

Mean serum retinol levels among the diabetic men and women were above the cutoff point of 0.7 μmoles per liter; however 13 % of the men were biochemically deficient in plasma retinol (> 0.5 and < 0.7 μmoles per liter). Prevalence of smokers was 13 % among diabetic men , but smoking habits had no effect on the serum retinol level. Initial plasma retinol concentrations among the females correlated inversely with glycosylated hemoglobin [r = -0.4212; P<0.01] with a regression equation of Y= 1.882 - 0.0809 X (Y= Predicted plasma retinol concentration; X= glycosylated hemoglobin).

Identical initial mean serum RBP-4 concentrations of 31.8± 0.9 and 32.9 ± 1.1μg/ml (equivalent to 1.5±0.04 μmoles/l and 1.57± 0.05 μmoles/l) were obtained among the diabetic men and women, respectively. Respective mean molar ratios of retinol: RBP- 4 were 1.4 ± 0.18 and 1.41± 0.17. The molar RBP-4: retinol ratio correlated negatively with body mass index of the men and women with correlation coefficients of - 0.23 and - 0.66 (P<0.01) respectively. Fasting plasma glucose among diabetic men correlated positively with post prandial glucose, HbA1C, duration of diabetes and systolic blood pressure.

figure 5
Figure 5: Plasma β- carotene, lycopene and retinol levels among controls and those receiving tomato juice for 21 days. Boxes represent the interquartile range (IQR) and the line inside represents the median. Whiskers denote the lowest and highest values.

4. Discussion

It is estimated that 20% (18 -33%) of the aging population have T2DM and another 30% of old people have impaired glucose regulation which means an increased risk for DM [35]. Population growth, aging of population and urbanization with associated lifestyle change is likely to lead to a 55% increase in worldwide numbers with diabetes by 2035 [36]. In Egypt population over 60 years represent 4 % of the 100 million population estimate. Accordingly, roughly 800000 Egyptians over 60 years are suffering from T2DM. The present results highlight the burden of poorly controlled diabetes with co-existing morbidities and lower ratings of their overall health and limited access to specialty care to address multi-complex management needs. Metabolic syndrome (MS) contributes to increasing risk of developing cardiovascular disease [37]. Similar metabolic disorders and comorbidities were reported for diabetics from Canada [38], China [39], Hawai [40] and Malaysia [41]. Treatment for diabetics consists of reducing hyperglycemia through diet, exercise, and therapy with drugs or insulin. Despite insulin treatment, hyperglycemia in these patients is often not well controlled and effective clinical management is problematic. Oxidative stress, due to free radical over production has been implicated in the pathogenesis of DM and to pancreatic β-cell dysfunction [4]. Identifying individuals with abnormal glucose regulation enables intensified preventive measures to be undertaken earlier and at effective cost [31]. DM was defined as FPG ≥ 7.0 μ mol/L [42]. In 2009, the American Diabetes Association [43] recommended using a threshold of HbA1c ≥ 6.5% to diagnose diabetes. Glycated hemoglobin (HbA1c) is an important glycemic index that indicates average blood glucose levels over the previous 3-4 months. HbA1c tests are convenient and can be performed at any time regardless of the time of the previous meal [44]. Some studies had demonstrated that combined use of FPG and HbA1c are necessary [45].

The high significant correlation coefficients between FPG and HbA1c of 0.5321 and 0.9151 among the diabetic men and women, respectively agrees with earlier reports [46]. HbA1c, diabetes duration and diastolic pressure are significantly related to a higher risk of developing metabolic syndrome [47].

A prospective cardiovascular study carried out on middle-aged Canadian men showed that reduced plasma HDL-cholesterol concentrations have a greater impact than raised LDL-cholesterol on the atherogenic index (total cholesterol/ HDL-cholesterol ratio) [38], and the authors considered raising plasma HDL-cholesterol through a healthy diet, and proper pharmacotherapy is a target for the optimal prevention of CHD in a large proportion of high risk patients.

Lycopene (80–90%) the predominant carotenoid pigment responsible for the red colour in tomatoes is an aliphatic hydrocarbon (C40H56) with 13 double bonds; 11 of them being conjugated. It exhibits the highest physical quenching rate constant with singlet oxygen, implicated in the defense against prooxidant state [48]. Interest in lycopene was firstly focused on its antioxidant properties, however their beneficial effects are related also to other mechanisms, such as immune system, inflammation response [49,50] and regulatory molecules associated with cell proliferation, and by contributing to intracellular signaling [51,52]. Serum and tissue lycopene are validated biomarkers for the exposure to tomato intake and its significant increase in the plasma suggests possible protective roles in reducing risk of progression of DM pathogenesis, improving glycemic control in patients who had poorly controlled type II diabetes despite therapy with insulin or with oral drugs. Significant linear decrease in lycopene was reported in Americans with newly diagnosed diabetes [53] and all the carotenoids were inversely related to fasting insulin concentration. Variation of serum carotenoid concentrations were attributed to impaired glucose tolerance or diabetes which impaired the absorption of various carotenoids from the intestinal lumen.

Between 79–91% of the lycopene found in raw tomatoes is in the all-trans- form [54,55]and the mild cooking and steaming of tomato juice has dramatic positive effect on the disruption of cells and converting lycopene to the Cis-isomer [56,57]. Eating concentrated tomato-based foods like pasta sauce with Cis-isomers of lycopene are better absorbed than their all-trans parent structure due to greater solubility of cis-isomers in mixed micelles and a lower tendency to aggregate [56,58]. 50-90% of serum and tissue lycopene are in cislycopene isomers [56,59].

The mean baseline plasma lycopene concentrations 0.42±0.06 μmol/L among diabetic men and 0.8± 0.2 μmol /L among diabetic women; the last figure is quite overlapping with the respective figure of 0.75 reported among patients with mean diabetes duration of 23 years, and HbA1c of 8.5% [60]. The lower levels of plasma provitamin A carotenoids and retinol among men compared to women was attributed to higher vitamin A requirements in men [61]. Race or gender differences about the serum levels of carotenoids and associations with the risk for developing T2 DM had been reported [62].

In the present study tomato juice was subjected to thermal treatment using live steam as recommended earlier [63] to convert the all-trans lycopene to the cis- form.

The tomato lycopene (14.85 mg/100g ) and β-carotene (0.53 mg/100g) contents overlapped the respective levels of 0.86-14.62 mg per 100 g tomato grown in Europe [64]. In the present study, the magnitude of the change in the plasma lycopene concentration ranged from 73 to 290 % the respective baseline level with average fold excess of 162 ± 30% (P < 0.1) following three week intakes of 240 ml thermally treated tomato juice providing 22 mg lycopene daily. High inter individual variation is evident and is in line with previous findings [65]. Serum lycopene levels showed the highest ratio for intra- to inter individual variation of 0.57; compared with other serum carotenoids and 7 serum measurements of lycopene are required to reach the 10% cutoff [65]. Significant diet serum lycopene correlation averaged 0.50 [66]. Adipose tissue lycopene concentration reflect storage depot levels and was inversely associated with risk for myocardial infarction [67]. Consuming about 200g of raw tomatoes daily for 8 weeks successfully lowered both systolic and diastolic blood pressure in diabetics due to a reduction in activity of angiotensin converting enzyme (ACE), an effect produced by common antihypertensive drugs [68]. Daily consumption of two glasses of tomato juice providing 40 mg of lycopene substantially reduced low density lipoprotein (LDL) oxidation; a signature for risk of atherosclerosis and coronary heart disease. Another study demonstrated that consuming a lycopene-rich Mediterranean diet increased serum lycopene levels and reduced the concentration of HbA1c from 7.1 to 6.8% [69]. The lycopene concentration increased (0.34 to 0.52 μmol/l) significantly in the plasma of Italian female adults after consuming tomato products providing 8mg lycopene per day for three weeks with associated 20% mean decrease in lymphocyte malondialdehyde levels [70].

Daily consumption of 12.5 mg lycopene comprised in tomatoes (145-320 g), tomato juice (94-100g) or in puree (25-28 g) for 4 weeks increased the concentration of lycopene from 0.25 μmol/L at baseline to comparable values ranging between 0.53-0.81 μmol/L for the 3 groups [71].

Supplementation with cooked tomatoes for a period of 30 days decreased lipid peroxidation rate (p<0.001) in diabetic patients [72]. Another group of investigators showed that the daily intake of 30 mg of lycopene by older diabetic women reduced total and LDL cholesterol by 12 and 16% respectively, and also lowered common marker of tissue oxidation that contributes to atherosclerosis [73]. The available clinical research and systematic analysis obtained from 13 different randomized controlled trials (RCTs) demonstrated superiority of whole food tomato lycopene versus lycopene supplement on cardiovascular risk factors [74,75]. Because tomato are chemically complex food wit potential beneficial substances including lycopene and other carotenoids; antioxidant vitamins and flavonoids, it is difficult to pinpoint any single nutrient that contributes the most to the protective effects.

5. Strengths and Limitation

The intake of thermally treated tomato juice increased the plasma lycopene by 162% compared to the respective prefeeding levels reflecting lowering in the oxidative stress and improving glycemic control among patients with (T2DM). Further studies are warranted to examine factors associated with the lower absorption rate of lycopene. The small sample size (N = 29) is the major limitation of the study leading to low statistical power and confidence intervals that may be difficult to interpret. A population-based study is warranted to highlight the association between the increase in plasma lycopene level and measures that could help prevent dysglycemia and dyslipidaemia with their negative sequelaes.

6. Conclusion

Pronounced health effects of the antioxidant-rich tomato lycopene can be used safely as an adjunct to glucose-lowering drugs in diabetics with poorly glycaemic control.

Competing Interests

The authors declare that they have no competing interests.

Acknowledgments

This work was supported by the Egyptian Italian Scientific Agreement (contract Bioscience # 11). The authors are thankful to Dr Mahmoud Ali-Department of Nutrition, National research center, Egypt, who kindly carried out the assay of serum C- peptide. The authors are grateful to all participants and to the physicians.


References

  1. WHO (2016) Global report on diabetes. Diabetes Mellitus – epidemiology, prevention and control. WHO, Geneva, Switzerland
  2. Shu L, Shen XM, Li C, Zhang XY, Zheng PF, et al. (2017) Dietary patterns are associated with type 2 diabetes mellitus among middle-aged adults in Zhejiang Province, China. Nutr J 16: 81 [CrossRef] [Google Scholar] [PubMed]
  3. McCulloch DK, Munshi M, Nathan DM, Schmader KE, Mulder JE, et al. (2017) Treatment of type 2 diabetes mellitus in the older patient.UpTodate [View]
  4. Franz MJ, Boucher JL, Rutten-Ramos S, VanWormer JJ (2015) Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials. J Acad Nutr Diet 115: 1447-1463 [CrossRef] [Google Scholar] [PubMed]
  5. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, et al. (2001) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345: 790-797 [CrossRef] [Google Scholar]
  6. Nowotny K, Jung T, Hӧhn A, Weber D, GruneT, et al. (2015) Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules 5: 194-222 [CrossRef] [Google Scholar] [PubMed]
  7. Wada R, Yagihashi S (2005) Role of advanced glycation end products and their receptors in development of diabetic neuropathy. Ann N Y Acad Sci 1043: 598-604 [CrossRef] [Google Scholar] [PubMed]
  8. Vistoli G, De Maddis D, Cipak A, Zarkovic N, Carini M et al. (2013) Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radical Research 47: 3-27 [CrossRef] [Google Scholar] [PubMed]
  9. Bray GA, Nielsen SJ, Popkin BM (2004) Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J ClinNutr 79: 537-543 [CrossRef] [Google Scholar] [PubMed]
  10. Horst K W, Schene MR, Holman R, Romijn JA, Serlie MJ, et al. (2016) Effect of fructose consumption on insulin sensitivity in nondiabetic subjects: a systematic review and meta-analysis of diet-intervention trials. AJCN 104: 1562-1576 [CrossRef] [Google Scholar] [PubMed]
  11. Turk Z, Mesić R, Benko B (1998) Comparison of advanced glycation end products on haemoglobin (Hb-AGE) and haemoglobin A1c for the assessment of diabetic control. ClinChimActa 277: 159-170 [CrossRef] [Google Scholar] [PubMed]
  12. Cerf ME (2013) Beta cell dysfunction and insulin resistance. Front Endocrinol 4: 37 [CrossRef] [Google Scholar] [PubMed]
  13. Kalyani RR, MD, Egan JM (2013) Diabetes and altered glucose metabolism with aging. MetabClinEndocrinol 42: 33-347 [CrossRef] [Google Scholar] [PubMed]
  14. Montonen J, Knekt P, Jarvinen R (2004) Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 27: 362-366 [CrossRef] [Google Scholar] [PubMed]
  15. Wu W, Brickman AM, Luchsinger J, Ferrazzano P, Pichiule P, et al. (2008) The brain in the age of old: Hippocampal formation is targeted differentially by diseases of late life. Ann Neurol 64: 698-706 [CrossRef] [Google Scholar] [PubMed]
  16. Hanssen KF (1997) Blood glucose control and microvascular and macrovascular complications in diabetes. Diabetes 46: S101-S103 [CrossRef] [Google Scholar] [PubMed]
  17. Kitabchi AE (1977) Proinsulin and C-peptide: a review. Metabolism 26: 547- 587 [CrossRef] [Google Scholar] [PubMed]
  18. Leighton E, Sainsbury CAR, Jones GC (2017) A practical review of C-peptide testing in diabetes. Diabetes Ther 8: 475-487 [CrossRef] [Google Scholar] [PubMed]
  19. Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T, et al. (2007) Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J ClinEndocrinol Metabolism 92: 2712-2719 [CrossRef] [Google Scholar] [PubMed]
  20. Shi J, Le MaguerM (2000) Lycopene in tomatoes: chemical and physical properties affected by food processing. Crit Rev Biotechnol 20: 293-334 [CrossRef] [Google Scholar] [PubMed]
  21. Lazarus SA, Bowen K, Garg ML (2004) Tomato juice and platelet aggregation in Type 2 Diabetes. JAMA; 292: 805-806 [CrossRef] [Google Scholar] [PubMed]
  22. Khachik F, Goli MB, Beecher GR, Holden J, Lusby WR, et al. (1992) Effect of food preparation on qualitative and quantitative distribution of major carotenoid constituents of tomatoes and several green vegetables. JAgric Food Chem 40: 390-398 [CrossRef] [Google Scholar]
  23. Brazionis L, Rowley K, Itsiopoulos C, O'DeaK (2009) Plasma carotenoids and diabetic retinopathy. Br J Nutr 101: 270-277 [CrossRef] [Google Scholar] [PubMed]
  24. Kiho T, Usui S, Hirano K, Aizawa K, Inakuma T, et al. (2004) Tomato paste fraction inhibiting the formation of advanced glycation end products. BioscBiotechnolBiochem 68: 200-205 [CrossRef] [Google Scholar] [PubMed]
  25. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, without Use of the Preparative Ultracentrifuge. Clinical Chemistry 18: 499-502 [Google Scholar] [PubMed]
  26. Craft NE, Brown ED, Smith C (1988) Effects of storage and handling conditions on concentrations of individual carotenoids, retinol, and tocopherol in plasma. ClinChem 34: 44-48 [Google Scholar] [PubMed]
  27. Britton G (1995) Absorption coefficients of common carotenes. In:"Britton G, Liaen-Jensen S, Pfander H. Editors "Carotenoids spectroscopy". 18; pp13-63.BirkhauserVerlag
  28. De LeenheerAP, De RevereVO, De RuyterMG, Claeys AE (1979) Simultaneous determination of retinol and a-tocopherol in human serum by high-performance liquid chromatography. J. Chromatogr 162: 408-413 [CrossRef] [Google Scholar] [PubMed]
  29. Hussein L, Ali M (2000) Cord plasma retinol level and its impact on birth weight and growth velocity in infancy. Nutr Res 20: 1361-1366 [CrossRef] [Google Scholar]
  30. Khachik F, Carvalho L, Bernstein PS, Muir GJ, Zhao DY, et al. (2002) Chemistry, distribution, and metabolism oftomato carotenoids and their impact on human health. ExpBiol Med 227: 845-851 [CrossRef] [Google Scholar] [PubMed]
  31. WHO IDF consultation report (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Geneva, Switzerland [Google Scholar]
  32. Klein BEK, Klein R, Lee KE (2002) Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes care 25: 1790-1794 [CrossRef] [Google Scholar] [PubMed]
  33. Jones AG, Hattersley AT (2013) The clinical utility of C-peptide measurement in the care of patients with diabetes. DiabetMed 30: 803-817 [CrossRef] [Google Scholar] [PubMed]
  34. Steffes MW, Sibley S, Jackson M, Thomas W (2003) Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care 26: 832-836 [CrossRef] [Google Scholar] [PubMed]
  35. Chentli F, Azzoug S, Mahgoun S (2015) Diabetes mellitus in elderly. Indian J Endocrinol Metab. 19: 744-752 [CrossRef] [PubMed]
  36. Li S, Guo S, He F, Zhang M, He J, et al. (2015) Prevalence of diabetes mellitus and impaired fasting glucose, associated with risk factors in rural Kazakh adults in Xinjiang, China. Int J Environ Res Public Health 12: 554- 565 [CrossRef] [Google Scholar] [PubMed]
  37. Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D, et al. (2012) Metabolic syndrome and risk of cancer. Diabetic care 35: 2402-2411 [CrossRef] [PubMed]
  38. Arsenault BJ, Rana JS, Stroes ESG, Després JP, Shah PK et al. (2009) Beyond low-density lipoprotein cholesterol: Respective contributions of non–high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. J Am College Cardiol; 55: 35-41 [CrossRef] [Google Scholar] [PubMed]
  39. Chen Y, Liu L, GuL, Babineaux S, Colclough H, et al. (2015) Glycemic control in Chinese patients with type 2 diabetes mellitus receiving oral antihyperglycemic medication-only or insulin-only treatment: A crosssectional survey. Diabetes Ther 6: 197-211 [CrossRef] [Google Scholar] [PubMed]
  40. BA JK, Delafield R, Davis J, Mau MK (2013) Characteristics of patients with Type 2 diabetes mellitus in two rural, medically underserved communities. Hawai‘I. J Medicine Public Health 72: 191-196 [Google Scholar] [PubMed]
  41. Mohamed E, Mohamed M, Rashid FA (2004) Dyslipidemia pattern of patients with type 2 diabetes mellitus. Malaysian J Med Sci 11: 44-51 [PubMed]
  42. WHO Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO (1999) World Health Organization. World Health Organization - Geneva – Switzerland
  43. American Diabetes Association (2009) Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 32: S62-S67 [CrossRef] [Google Scholar] [PubMed]
  44. Incani M, Sentinelli F, Perra L, Pani MG, Porcu M, et al. (2015) Glycated hemoglobin for the diagnosis of diabetes and prediabetes: Diagnostic impact on obese and lean subjects, and phenotypic characterization. J Diabetes Invest 6: 44-50 [CrossRef] [Google Scholar] [PubMed]
  45. Hu Y, Liu W, Chen Y, Zhang M, Wang L, et al. (2010) Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance. Acta Diabetol 47: 231-236 [CrossRef] [Google Scholar] [PubMed]
  46. Mayega RW, Guwatudde D, MakumbiFE, Nakwagala FN, Peterson S, et al. (2014) Comparison of fasting plasma glucose and haemoglobin A1c pointof- care tests in screening for diabetes and abnormal glucose regulation in a rural low income setting. Diabetes Research Clinical Practice 104: 112-120 [CrossRef] [Google Scholar] [PubMed]
  47. Wang J, Zhang RY, Chen RP, Sun J, Yang R, et al. (2013) Prevalence and risk factors for diabetic retinopathy in a high-risk Chinese population. BMC Public Health 13: 633 [CrossRef] [Google Scholar] [PubMed]
  48. Di Mascio P, Kaiser S, SiesH (1989) Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274: 532-538 [CrossRef] [Google Scholar] [PubMed]
  49. Palozza P, Simone R, Catalano A, Boninsegna A, Böhm V, et al. (2010) Lycopene prevents 7-ketocholesterol-induced oxidative stress, cell cycle arrest and apoptosis in human macrophages. J Nutr Biochem 21: 34-46 [CrossRef] [Google Scholar] [PubMed]
  50. Ried K, Fakler P (2011) Protective effect of lycopene on serum cholesterol and blood pressure: Meta-analyses of intervention trials. Maturitas 68: 299- 310 [CrossRef] [Google Scholar] [PubMed]
  51. Krutovskikh V, Asamoto M, Takasuka N, Murakoshi M, Nishino H, et al. (1997) Differential dose-dependent effects of alpha-, beta-carotenes and lycopene on gap junctional intercellular communication in rat liver in vivo. Jpn J Cancer Res 88: 1121-1124 [CrossRef] [Google Scholar] [PubMed]
  52. Leone A, Longo C, Trosko JE (2012) The chemopreventive role of dietary phytochemicals through gap junctional intercellular communication. Phytochem Rev 11: 285-307 [Google Scholar]
  53. Ford ES, Will JC, Bowman BA, Venkat Narayan KM (1999) Diabetes mellitus and serum carotenoids: Findings from the Third national health and nutrition examination survey. Am J Epidemiol 149: 168-176 [CrossRef] [Google Scholar] [PubMed]
  54. Clinton SK, Emenhiser C, Schwartz SJ, Bostwick DG, Williams AW, et al. (1996) Cis-trans lycopene isomers,carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev 5: 823-833 [Google Scholar] [PubMed]
  55. Hadley CW, Clinton SK, Schwartz SJ (2008) The consumption of processed tomato products enhances plasma lycopene concentrations in association with a reduced lipoprotein sensitivity to oxidative damage. Am J Clin Nutr 133: 727-732 [CrossRef] [Google Scholar] [PubMed]
  56. Stahl W, Sies H (1992) Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans. J Nutr 122: 2161-2166 [CrossRef] [Google Scholar] [PubMed]
  57. Erdman JW (2005) How do nutritional and hormonal status modify the bioavailability, uptake, and distribution of different isomersof lycopene? J Nutr 135: 2046S-2047S [CrossRef] [Google Scholar] [PubMed]
  58. Britton G (1995) Structure and properties of carotenoids in relation to function. FASEB J 9: 1551- 1558 [CrossRef] [Google Scholar] [PubMed]
  59. Boileau AC, Merchen NR, WassonK, Atkinson CA, Erdman JW, et al. (1999) Cis-lycopene is more bioavailable than Trans-lycopene in vitro and in vivo in lymph-cannulatedferre. J Nutr 129: 1176-1181 [CrossRef] [Google Scholar] [PubMed]
  60. Porrini 55- Riso P, Brusamolino A, Berti C, Guarnieri S, Visioli F, et al. (2005) Daily intake of a formulated tomato drink affects carotenoid plasma and lymphocyte concentrations and improves cellular antioxidant protection. Br J Nutr 93: 93-99 [CrossRef] [Google Scholar] [PubMed]
  61. Thurnham DI, Flora PS (1988) Do higher vitamin A requirements in men explain the difference between the sexes in plasma provitamin A carotenoids and retinol. Proc Nutr Soc 47: 181A
  62. Sugiura M, Mieko Nakamura M, Ogawa K, Ikoma Y, Yano M, et al. (2015) High-serum carotenoids associated with lower risk for developing type 2 diabetes among Japanese subjects: Mikkabi cohort study. BMJ Open Diabetes Res Care 3: 000147 [CrossRef] [Google Scholar] [PubMed]
  63. Unlu NZ, Bohn T, Francis DM, Nagaraja HN, Clinton SK, et al. (2007) Lycopene from heat-induced cis-isomer-rich tomato sauce is more bioavailable than from all-trans-rich tomato sauce in human subjects. Br J Nutr 98: 140-146 [CrossRef] [Google Scholar] [PubMed]
  64. Alda LM, GogoaşăI, Bordean DM, Gergen I, Alda S, et al. (2009) Lycopene content of tomatoes and tomato products. JAP & T 15: 540-542 [CrossRef] [Google Scholar]
  65. Forman MR, Borkowf CB, Cantwell MM, Steck S, Schatzkin A, et al. (2009) Components of variation in serum carotenoid concentrations: the Polyp prevention trial. Europ J Clin Nutr 63: 763–770 [CrossRef] [Google Scholar] [PubMed]
  66. Yong LC, Forman MR, Beecher GR, Graubard BI, Campbell WS, et al. (1994) Relationship between dietary intake and plasma concentrations of carotenoids in premenopausal women: application of the USDA-NCI carotenoid food-composition database. AAm J ClinNutr 60: 223-230 [CrossRef] [Google Scholar] [PubMed]
  67. Kohlmeier L, Kark JD, Gomez-Gracia E, Martin BC, Steck SE et al. (1997) Lycopene and myocardial infarction risk in the EURAMIC study. Am J Epidemiol 146: 618-626 [CrossRef] [Google Scholar] [PubMed]
  68. Shidfar F, Froghifar N, Vafa M, Rajab A, Hosseini S, et al. (2011) The effects of tomato consumption on serum glucose, apolipoprotein B, apolipoprotein A-I, homocysteine and blood pressure in type 2 diabetic patients. Int J Food Sci Nutr 62: 289-294 [CrossRef] [Google Scholar] [PubMed]
  69. Itsiopoulos C, Brazionis L, Kaimakamis M, Cameron M, Best JD, et al. (2011) Can the Mediterranean diet lower HbA1c in type 2 diabetes? Results from a randomized cross-over study. Nutr Metab Cardiovasc Dis. 21: 740- 747 [CrossRef] [Google Scholar] [PubMed]
  70. Riso P, Visioli F, Erba D, Testolin G, Porrini M, et al. (2004) Lycopene and vitamin C concentrations increase in plasma and lymphocytes after tomato intake. Effects on cellular antioxidant protection. Eur J ClinNutr 58: 1350- 1358 [CrossRef] [Google Scholar] [PubMed]
  71. Frohlich K, Kauffmann K, Bitsch R, Bohm V (2006) Effects of ingestion of tomatoes, tomato juice and tomato puree on contents of lycopene isomers, tocopherols and ascorbic acid in human plasma as well as on lycopene isomer pattern. Br J Nutr 95: 734-741 [CrossRef] [Google Scholar] [PubMed]
  72. Subhash K, Bose C, Agrawal BK (2007) Effect of short term supplementation of tomatoes on antioxidant enzymes and lipid peroxidation in type-II diabetes. Indian J Clin Biochem 22: 95-98 [CrossRef] [Google Scholar] [PubMed]
  73. Upritchard JE, Sutherland WH, Mann JI (2000) Effect of supplementation with tomato juice, vitamin E and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care 23: 733-738 [CrossRef] [Google Scholar] [PubMed]
  74. Cheng HM, Koutsidis G, Lodge JK, Ashor A, Siervo M, et al. (2017) Tomato and lycopene supplementation and cardiovascular risk factors: A systematic review and meta-analysis. Atherosclerosis 257: 100-108 [CrossRef] [Google Scholar] [PubMed]
  75. Burton-Freeman B, Sesso HD (2014) Whole food versus supplement: comparing the clinical evidence of tomato intake and lycopene supplementation on cardiovascular risk factors. AdvNutr 5: 457-485 [CrossRef] [Google Scholar] [PubMed]